Phase II Study of Neoadjuvant Dostarlimab in Patients With Untreated T3-4N0-2 or Stage III pMMR/MSS Resectable Colon Cancer
Clinical trial NCT06830239 · RECRUITING
Trial details
- NCT number
- NCT06830239
- Sponsor
- Universitaire Ziekenhuizen KU Leuven
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-03
- Primary completion
- 2027-12-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.